Pradaxa Lawsuits Allege Severe and Potentially Fatal Bleeding
More lawsuits have reportedly been added to the Pradaxa litigation against drug maker Boehringer Ingelheim, even after it agreed to pay more than $650 million in settlements in […]
Study Compares Pradaxa, Xarelto Gastrointestinal Risks to Warfarin’s
Pradaxa and Xarelto gastrointestinal bleeding risks were compared to a more traditional blood thinner, warfarin, in a study published in the April 24, 2015 edition of the British […]
Warfarin, Pradaxa Side Effects Compared in 2014 Study
Pradaxa, manufactured and marketed by Boehringer Ingelheim Pharmaceuticals, is a blood thinner that has been linked in studies to an increased risk of internal bleeding. Pradaxa lawsuits have […]
Blood Thinners Xarelto, Pradaxa Among Drugs Companies Pay Most to Promote
In the last five months of 2013, drug makers spent nearly $20 million to promote medications hospitals and healthcare providers. Among the top 20 drugs listed by Business Insider that companies pay […]
Xarelto Antidote
When Xarelto and other newer blood thinners were released to the public, they were touted as a better solution to prevent blood clots than Coumadin, also known as warfarin, […]
Patients Used to Test Those on Bad Drug List
The bad drug list has been in existence for years, often because big pharmaceutical companies push the use of blockbuster drugs to healthcare practitioners. Blockbuster drugs are those […]
Call us today for your free case review(888) 888-0612
Pradaxa Bleeding Is a Common Concern
In what appears to be a rush by the pharmaceutical companies to push new medications to market, problems with many of those medications are becoming more common. The […]
Could Pradaxa Litigation be the Cause of a Drop in Manufacturer Sales?
Boehringer Ingelheim, the German manufacturer of Pradaxa, has seen a five-percent loss in sales over the first half of 2014. During that time the company encountered a number […]
U.S. Set Record Drug Recalls in 2014
The Regulatory Affairs Professionals Society has released a report in which the organization estimates that the number of drug recalls in 2014 may be the highest in history. The U.S. […]
Pradaxa Treatments Approved for Use in the UK
As of July 15th, 2014, Pradaxa treatments are approved in the United Kingdom (UK) to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT and PE are […]
New Pradaxa Study on Patients with Atrial Fibrillation
The German pharmaceutical company Boehringer Ingelheim, which manufactures the oral anticoagulant drug Pradaxa, has launched a new Pradaxa study examining how patients with atrial fibrillation react to using […]
Lawsuits Filed Over Alleged Xarelto Issues
Last week, a Florida plaintiff brought a Xarelto lawsuit alleging certain Xarelto issues in federal court. The plaintiff seeks damages sustained by her and her deceased husband who […]
Choose HopeGet a Free Case Review
Antidote Hailed as a Pradaxa Breakthrough
A new antidote, developed by Boehringer Ingelheim, is being hailed as a Pradaxa breakthrough. Pradaxa, a prescription blood thinning agent that reduces the risk of stroke in patients […]
Adverse Event Reports from Xarelto Patients
Xarelto, an anticoagulant used in the treatment and prevention of deep vein thrombosis, is a prescription-only drug in tablet form. The generic form of the medication is Revaroxaban. […]
Boehringer Ingelheim Announces $650M Pradaxa Settlement
Boehringer Ingelheim announced on May 28, 2014 an agreement to settle litigation involving their prescription blood thinner Pradaxa (dabigatran). The company estimates that the Pradaxa settlement of $650 […]